KLRC1 and neoplasm: While NK cells were able to control tumor growth and metastasis, ILC1s and intILC1s upregulated tumor progression and resistance-related pathways with a higher expression of inhibitory receptors (NKG2A, KLRG1) and the production of PDGF-AB, a pro-angiogenic molecule.